Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

A Bouma-de Krijger, FJ van Ittersum… - Clinical kidney …, 2019 - academic.oup.com
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 …

AB Krijger, FJ van Ittersum, T Hoekstra… - Clinical Kidney …, 2019 - search.ebscohost.com
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 …

A Bouma-de Krijger, FJ van Ittersum… - Clinical Kidney …, 2019 - europepmc.org
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 …

A Bouma-de Krijger, FJ van Ittersum… - Clinical Kidney …, 2019 - cabdirect.org
Background: High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

A Bouma-de Krijger, FJ van Ittersum… - Clinical kidney …, 2019 - pubmed.ncbi.nlm.nih.gov
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

A Bouma-de Krijger… - Clinical …, 2019 - researchinformation.amsterdamumc …
Background: High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 …

A Bouma-de Krijger, FJ Ittersum, T Hoekstra, PM Wee… - 2019 - cabidigitallibrary.org
Background: High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

[PDF][PDF] Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease …

A Bouma-de Krijger, FJ van Ittersum… - Clinical Kidney …, 2019 - pdfs.semanticscholar.org
Background. High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

AB de Krijger, FJ van Ittersum, T Hoekstra… - Clinical Kidney …, 2019 - go.gale.com
Background. High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …

[HTML][HTML] Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease …

A Bouma-de Krijger, FJ van Ittersum… - Clinical Kidney …, 2019 - ncbi.nlm.nih.gov
Background High concentrations of both phosphate and fibroblast growth factor 23 (FGF23)
observed in chronic kidney disease (CKD) are associated with an increased risk of …